Historically, RSV has been studied mainly in infants and older adults, but recent research shows that it also poses a ...

A single dose of respiratory syncytial virus vaccine was effective against infections and associated hospitalizations in veterans aged at least 60 years during the 2023-24 season.

Among older adults in Spain, hospitalization rates from respiratory syncytial virus (RSV) infection increases progressively ...

Risk factors for RSV transmission included index case viral detection 1 week or more after an index case and a household contact age of 12 years or younger. Of 120 sequenced specimens, the main ...

Hospitalization rates from respiratory syncytial virus (RSV) infection rose with age. Also, hospitalizations were more likely among nursing home residents and older adults with other health issues, ...

A study from Yale University today in JAMA Network Open reveals substantial protection by the preventive drug nirsevimab ...

MANILA, Philippines — Respiratory Syncytial Virus (RSV) is a common, contagious virus affecting the lungs and breathing ...

A recent study reveals that infants and young children are the primary transmitters of respiratory syncytial virus (RSV) ...

On 12 March 2025, the World Health Organization (WHO) prequalified the first maternal respiratory syncytial virus (RSV) vaccine to protect infants ...

Nirsevimab-resistant respiratory syncytial virus variants remain rare, but continued molecular surveillance is crucial. Read ...

RSV leads to approximately 1.4 million hospitalizations and over 13,000 in-hospital deaths worldwide among infants under six ...

Uruguay's Public Health Ministry (MSP) launched its 2025 vaccination campaign, focusing on influenza, measles, and ...